EU-MDR: Diversity, heterogeneity, and external Collaboratory validity in cardiovascular clinical trials

EpicPartner

Date: May 13th, 2024
Location: Paris, France
Registration: https://www.surveymonkey.com/r/56WZYMH

Welcome and Introduction: Ernest Spitzer (NL)

SESSION I: Coronary artery disease, devices, and diversity

Moderators: Donald Cutlip (USA), Armando Perez de Prado (ES), Nicolas Van Mieghem (NL)

I. Guömundsdóttir (IS) Sex differences on safety and efficacy of coronary devices
Wayne Batcherlor (USA) Racial/ethnic differences on safety and efficacy of coronary devices
Jose M. de la Torre (ES) Age differences on safety and efficacy of coronary devices

SESSION II: Structural heart disease, devices, and diversity

Moderators: Philippe Pibarot (CA), Eugene McFadden (IE), Eric Van Belle (FR)

Victoria Delgado (ES) Sex differences on safety and efficacy of transcatheter heart valves
Jeroen Bax (NL) Racial/ethnic differences on safety and efficacy of THVS
Luca Testa (IT) Age differences on safety and efficacy of transcatheter heart valves

SESSION III: Multi-stakeholder Forum

Moderators: Mitchell Krucoff (USA), Donald Cutlip (USA), Jan Tijssen (NL)

US-FDA Perspective: Lydia Glaw (USA)
TEAM-NB Perspective: Ricard Holborow (UK)
Patients Perspective: Wil Woan (UK)
Scientific Media Perspective: Will Date (UK)
Statistician’s Perspective: Eric Boersma (NL) GCP/Legal Perspective….
Industry Perspective: Dominic Alloco (BSC), Becky Inderbitzen (Philips), Sonja Dietzsch (Siemens
Healthineers)

KEYNOTE SPEAKER

Philippe Pibarot (CA) Optimizing Management and Outcomes of Aortic Stenosis in Women

EU-MCVC & MDEpiNet Next Steps: Ernest Spitzer (NL) & Mitchell Krucoff (USA)

In collaboration with: Cardialysis

Comparte este artículo: